| 15973/34347 | US=21 / Patologia Petersen RO, Sesterhenn IA, Davis CJ. Scrotum. In: ___. Urologic pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 601-12. ISBN 978-0-7817-5343-2. SACO ESCROTAL. ANATOMIA; LIPOGRANULOMA ESCLEROSANTE; CALCINOSE IDIOPATICA DO ESCROTO; HAMARTOMA FIBROSO DA INFANCIA; CANCER DO SACO ESCROTAL |
| 15974/34347 | US=6 / Quimioterapia Airley R. Cancer epidemiology. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 1-10. ISBN 978-0-470-09254-5. EPIDEMIOLOGIA DO CANCER; INCIDENCIA DO CANCER; CANCER NA INFANCIA; INCIDENCIA DE MORTALIDADE |
| 15975/34347 | US=6 / Quimioterapia Airley R. Histopathology of cancer. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 11-8. ISBN 978-0-470-09254-5. HISTOPATOLOGIA DO CANCER; TECIDOS BENIGNO; TECIDOS MALIGNO NORMAIS; MORTE CELULAR |
| 15976/34347 | US=6 / Quimioterapia Airley R. Carcinogenesis, malignant transformation and progression. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 19-21. ISBN 978-0-470-09254-5. TRANSFORMACAO; CARCINOGENESE; PROGRESSAO MALIGNA; CARCINOGENESE QUIMICA |
| 15977/34347 | US=6 / Quimioterapia Airley R. Molecular biology of cancer: oncogenes and tumour suppressor genes. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 23-35. ISBN 978-0-470-09254-5. BIOLOGIA MOLECULAR DO CANCER; ONCOGENESE; GENES SUPRESSORES TUMORAIS |
| 15978/34347 | US=6 / Quimioterapia Airley R. Tumour metastasis: a convergence of many theories. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 37-48. ISBN 978-0-470-09254-5. TUMOR PRIMARIO; METASTASE DO TUMOR; TRANSPORTE; EXTRAVASAMENTO; CRESCIMENTO DA MASSA DO TUMOR METASTATICO |
| 15979/34347 | US=6 / Quimioterapia Airley R. Health professionals in the treatment of cancer. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 49-54. ISBN 978-0-470-09254-5. PROFISSIONAIS DE SAUDE NO TRATAMENTO DE CANCER; ONCOLOGISTA CIRURGICO. VISAO; FARMACIA EM ONCOLOGIA; ENFERMAGEM ONCOLOGICA; CANCER NHS |
| 15980/34347 | US=6 / Quimioterapia Airley R. Principles of cancer chemotherapy. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 55-65. ISBN 978-0-470-09254-5. PRINCIPIOS DA QUIMIOTERAPIA; TEMPORIZACAO DA QUIMIOTERAPIA; FARMACOGENETICA; FARMACOGENOMICA DE QUIMIOTERAPIA |
| 15981/34347 | US=6 / Quimioterapia Airley R. Classical anticancer agents. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 67-115. ISBN 978-0-470-09254-5. CLASSICOS AGENTES ANTICANCERIGENOS; AGENTE SUILANTES; ANTIMETABOLITOS; ANTIBIOTICOS ANTITUMORAIS; PRODROGAS ANTRACICLINA; SULCO DE LIGACAO DE AGENTES; INIBIDORES DA TOPOISOMERASE; INIBIDORES MITOTICOS; HORMONAIS AGENTES ANTICANCERIGENOS; REGIMES DE QUIMIOTERAPIA |
| 15982/34347 | US=6 / Quimioterapia Airley R. The philosophy of cancer research. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 117-23. ISBN 978-0-470-09254-5. PESQUISA DO CANCER; PESQUISA DO CANCER NO REINO UNIDO; PESQUISA SOBRE O CANCER NOS ESTADOS UNIDOS |
| 15983/34347 | US=6 / Quimioterapia Airley R. Novel anticancer agents. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 125-65. ISBN 978-0-470-09254-5. AGENTES ANTICANCERIGENOS; MANIPULACAO GENETICA DE LINHAS CELULARES; CELULAS TUMORAIS SHEROIDS; DROGAS DE CHUMBO; TRIAGEM; ATIVIDADE ANTICANCERIGENA IN VITRO; XENOENXERTOS TUMORES |
| 15984/34347 | US=6 / Quimioterapia Airley R. Clinical trials. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 167-75. ISBN 978-0-470-09254-5. EVOLUCAO NO TRATAMENTO; ENSAIOS CLINICOS; AVALIACAO DA VASCULARIZACAO; ANGIOGENESE PELA TECNOLOGIA DE MEDICINA NUCLEAR |
| 15985/34347 | US=6 / Quimioterapia Airley R. Tumour hypoxia. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 177-98. ISBN 978-0-470-09254-5. |
| 15986/34347 | US=6 / Quimioterapia Airley R. Antiangiogenic and antivascular agents. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 199-216. ISBN 978-0-470-09254-5. AGENTES ANTIANGIOGENICOS; AGENTES ANTIVASCULAR; HISTORIA DA ANGIOGENESE; ANTI-ANGIOGENICOS; TALIDOMIDA; ANTICORPOS; AGENTES ANTIANGIOGENICOS; AGENTES PERTURBADORES |
| 15987/34347 | US=6 / Quimioterapia Airley R. Tyrosine kinase inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 217-23. ISBN 978-0-470-09254-5. INIBIDORES DA QUINASE DE TIROSINA; NAO-RECEPTOR INIBIDORES DE TIROSINA |
| 15988/34347 | US=6 / Quimioterapia Airley R. Ras inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 225-8. ISBN 978-0-470-09254-5. |
| 15989/34347 | US=6 / Quimioterapia Airley R. Inhibitors of the AKT/PKB pathway. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 229-31. ISBN 978-0-470-09254-5. |
| 15990/34347 | US=6 / Quimioterapia Airley R. Targeting stress proteins: HSP90 inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 233-6. ISBN 978-0-470-09254-5. |
| 15991/34347 | US=6 / Quimioterapia Airley R. The proteasome. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 237-43. ISBN 978-0-470-09254-5. |
| 15992/34347 | US=6 / Quimioterapia Airley R. Checkpoint protein kinases as novel targets - mammalian target of rapamycin (mTOR). In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 245-8. ISBN 978-0-470-09254-5. CHECKPOINT; PROTEINAS QUINASES; MTOR; ALVO DA RAPAMICINA EM MAMIFEROS; ATIVACAO DE MTOR; ANTICANCERIGENOS ALVO MTOR |